Journal of the Korean Ophthalmological Society 2004;45(5):869-874.
Published online May 1, 2004.
Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization in Vogt-Koyanagi-Harada Syndrome.
Won Hyuck Oh, Hyeong Gon Yu, Hum Chung
1Department of Ophthalmology, Seoul National University College of Medicine, Korea. hgonyu@snu.ac.kr
2Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Korea.
Vogt-Koyanagi-Harada병에 합병된 황반하 맥락막신생혈관에 대한 Verteporfin을 이용한 광역학요법
오원혁 ( O Won Hyeog ) , 유형곤 ( Yu Hyeong Gon ) , 정흠 ( Jeong Heum )
Abstract
PURPOSE
We present a case of photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV) complicated by Vogt-Koyanagi-Harada syndrome. METHODS: A 46-year-old male who had bilateral subfoveal CNV complicated by Vogt-Koyanagi-Harada syndrome underwent 3 sessions of PDT with verteporfin in 1 year. RESULTS: After 3 sessions of PDT with verteporfin, maintenance of visual acuity was achieved without any complication as alteration of retinal pigment epithelium and aggravation of intraocular inflammation, but subfoveal fibrosis developed. CONCLUSIONS: PDT with verteporfin is a good treatment method without any complication for the CNV complicated by Vogt-Koyanagi-Harada syndrome, even though multiple sessions were needed.
Key Words: Choroidal neovascularization;Photodynamic therapy;Verteporfin;Vogt-Koyanagi-Harada syndrome


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next